Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02026492
Other study ID # KGU-208/13
Secondary ID
Status Completed
Phase N/A
First received December 19, 2013
Last updated March 16, 2015
Start date June 2013
Est. completion date July 2014

Study information

Verified date March 2015
Source Johann Wolfgang Goethe University Hospitals
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the exercise-challenge in a cold chamber at 2-4°C to the gold standard the metacholine challenge in subjects showing symptoms of exercise-induced bronchoconstriction. The sensitivity and repeatability of the exercise test will be measured.


Description:

Subjects suffering form exercise-induced bronchoconstriction (EIB) usually have a normal lung function testing at rest. To provoke asthma symptoms a provocation test is necessary, e.g., by bronchial methacholine testing or by a standardised exercise test on a treadmill. The correlation between methacholine and exercise test is fair, possibly because both methods measure different kinds of bronchial hyperresponsiveness. Moreover, the sensitivity and the repeatability of the exercise test is fair.

The value of the methacholine test to predict a positive exercise test will be measured. We hypothesize that the exercise test in a cold chamber, a combination of two provocation methods cold air and exercise, is more sensitive to detect EIB and that the test has a better repeatability.


Recruitment information / eligibility

Status Completed
Enrollment 79
Est. completion date July 2014
Est. primary completion date July 2014
Accepts healthy volunteers No
Gender Both
Age group 6 Years to 45 Years
Eligibility Inclusion Criteria:

- Informed consent

- Patients: Age >6 and <18 years

- Subjects: Age >/=18 and <45 years

- sportive, 1-2x exercise per week

- bronchial hyperresponsiveness in the medical history

Exclusion Criteria:

- lung function Forced vital capacity (FVC) <80% and Forced expiratory volume in 1 second (FEV1) <75%

- chronic diseases or infections (e.g. HIV, Tbc)

- pregnancy

- systemic corticosteroid-treatment

- inhalative corticosteroid therapy or leukotriene antagonists <14d

- alcohol, substance or drug abuse

- smokers

- inability to capture extend and consequences of the study

Study Design

Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
Exercise challenge in a cold chamber
Exercise challenge is defined as running on a treadmill for 6-8 minutes on submaximal work load in a cold chamber.
Methacholine challenge
nebulized metacholine administered at following doses: 0,01mg, 0,1mg, 0,4mg, 0,8mg und 1,6mg
Exercise challenge in room temperature
Exercise challenge is defined as running on a treadmill for 6-8 minutes on submaximal work load in room temperature.

Locations

Country Name City State
Germany Goethe University Hospital Frankfurt Frankfurt Hessen

Sponsors (1)

Lead Sponsor Collaborator
Johann Wolfgang Goethe University Hospitals

Country where clinical trial is conducted

Germany, 

References & Publications (5)

Anderson SD, Charlton B, Weiler JM, Nichols S, Spector SL, Pearlman DS; A305 Study Group. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res. 2009 Jan 23;10:4. doi: 10.1186/1465-9921-10-4. — View Citation

Anderson SD. Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010 Aug;138(2 Suppl):25S-30S. doi: 10.1378/chest.10-0116. Review. — View Citation

Driessen JM, van der Palen J, van Aalderen WM, de Jongh FH, Thio BJ. Inspiratory airflow limitation after exercise challenge in cold air in asthmatic children. Respir Med. 2012 Oct;106(10):1362-8. doi: 10.1016/j.rmed.2012.06.017. Epub 2012 Jul 11. — View Citation

Parsons JP, Hallstrand TS, Mastronarde JG, Kaminsky DA, Rundell KW, Hull JH, Storms WW, Weiler JM, Cheek FM, Wilson KC, Anderson SD; American Thoracic Society Subcommittee on Exercise-induced Bronchoconstriction. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 2013 May 1;187(9):1016-27. doi: 10.1164/rccm.201303-0437ST. — View Citation

Schulze J, Rosewich M, Riemer C, Dressler M, Rose MA, Zielen S. Methacholine challenge--comparison of an ATS protocol to a new rapid single concentration technique. Respir Med. 2009 Dec;103(12):1898-903. doi: 10.1016/j.rmed.2009.06.007. Epub 2009 Jul 10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Agreement of the combined exercise/cold-air challenge with the Asthma-score All children who participate will fill the asthma control test (ACT) and all adult subjects will fill the asthma control questionnaire (ACQ). The asthma-score will be compared with the severity of the exercise induced asthma measured by the maximal fall in FEV1. 3 months No
Primary Agreement of metacholine challenge and the combined exercise/cold-air challenge Lung function will be measured prior and after methacholine- and exercise/cold-air challenges. The maximal fall in forced expiratory volume in one second (FEV1, percent predicted) after methacholine and cold air challenge will be compared by statistical correlation. For both methods the sensitivity and the specificity to predict an exercise induced asthma will be calculated by a receiver operating characteristic (ROC analysis).
All subjects receive Salbutamol to relief them from bronchial constriction at the end of the test.
3 months No
Secondary Repeatability of the combined exercise/cold-air challenge The combined exercise/cold-air challenge will be performed twice within one week. Post challenge the FEV1 will be measured after 5, 10, 20, and 30 minutes. The maximal fall in FEV1 (percent predicted) and the area under the curve (AUC) will be compared. The agreement and the repeatability of the maximal fall in FEV1 and of the AUC will be measured by correlation and by the method of Bland and Altman. 3 months No
See also
  Status Clinical Trial Phase
Completed NCT00322283 - Study of Oglemilast for the Prevention of Asthma. Phase 2
Completed NCT00935415 - Time-Effect of Montelukast Protection Phase 4
Completed NCT02410096 - Bronchial Inflammation and Hyperresponsiveness After Oil Supplementation N/A